RESULTS

By working side by side with our researchers and clinicians and our partners in the biotech and pharmaceutical industry, we have helped bring patients four new treatments that have increased the survival of myeloma patients from four years to seven. Click here to learn more.

SCIENTIFIC AGENDA

Our scientific agenda – with its focus on basic science, validation, and clinical trials – allows us to move drug development forward – faster. Click here to learn more.

FOR ACADEMIC RESEARCHERS

As the leading funder of multiple myeloma research, the MMRF offers several prestigious high-value research grants to researchers at all levels of their career. Click here to learn more.

FOR INDUSTRY

The MMRF is working closely with partners in the pharmaceutical and biotech industry to advance the next generation of treatments. Click here to learn more.